Chemistry is the key to drug discovery, but chemical data is stuck in the twentieth century. We’re generating precise chemical datasets purpose-built to propel drug discovery into the information age — and we’re doing it on a larger scale and faster than has ever before been possible. Terray Therapeutics is a biotechnology company led by pioneers and long-time leaders in artificial intelligence, synthetic (medicinal) chemistry, biology and preclinical development, automation, and nanotechnology. Chemical datasets generated using our novel ultra-dense microarray technology work seamlessly with our integrated machine learning and computational platform to systematically map biochemical interactions between small molecules and causes of disease. Iterative cycles of virtual molecular design and experimentation power AI and machine learning models, which in turn guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise with every cycle, we can answer an unprecedented array of questions — deriving insights that enable us to predictably create drugs for patients in need.
Location: United States, California, Pasadena
Employees: 11-50
Total raised: $60M
Founded date: 2018
Investors 4
Date | Name | Website |
- | XTX Ventur... | xtxmarkets... |
25.11.2021 | Digitalis ... | digitalisv... |
17.02.2022 | Madrona Ve... | madrona.co... |
- | Two Sigma ... | twosigmave... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
16.02.2022 | Series A | $60M | Madrona Ve... | socaltech.... |
Mentions in press and media 5
Date | Title | Description | Source |
10.11.2023 | Terray Therapeutics Receives Investment from NVIDIA, et al | Terray Therapeutics, a Los Angeles, CA-based biotechnology company focused on small molecule drug di... | finsmes.co... |
16.02.2022 | Terray Therapeutics Takes $60M For Chemical Data | Pasadena-based Terray Therapeutics, a startup developing chemical datasets aimed at use in AI-driven... | socaltech.... |
15.02.2022 | Pasadena Biotech Terray Raises $60 Million to Speed Up Drug ... | After three years in stealth mode, a Pasadena biotech startup has emerged with $60 million and, it b... | dot.la/ter... |
15.02.2022 | Terray Therapeutics Raises $60M in Series A Funding | Terray Therapeutics, a Pasadena, CA-based biotechnology company, raised $60M in Series A funding. T... | finsmes.co... |
- | AI-biotech Terray emerges with $60M and a solution for data ... | Artificial intelligence-driven drug discovery can be like conducting an internet search. With each q... | medcitynew... |